We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Breath Test Detects Lung Cancer

By HospiMedica staff writers
Posted on 07 Dec 2006
It is possible to detect DNA methylation in the breath of smokers and lung cancer patients, suggesting that it may be possible to use this technique to identify people who have undiagnosed lung cancer or are at high risk of developing the disease. More...
DNA methylation is a kind of chemical modification of the cell's DNA, a process known to be associated with lung and other cancers.

The assay simultaneously detects the presence of methylation in six tumor-suppressor genes. Methylation is a process by which a gene is chemically silenced. The assay examines the promoter region of a gene where certain cytosine nucleotide bases may be methylated, preventing the gene from being expressed. To test the assay, people were asked to breathe for 10 minutes into a commercially available device, which cooled the air and formed a condensed vapor. Next, an assay was applied that detects chemical changes--specifically, a DNA methylated form of tumor-suppressor genes.

"The breath test was successful in finding cancer markers,” said Dr. Simon D. Spivack, a pulmonologist at the Wadsworth Center, the public health laboratory of the New York State Department of Health (Albany, NY, USA). The assay was presented at the annual meeting of the American Association for Cancer Research, held in Boston (MA, USA) in November 2006.

Doctors have long sought a reliable early detection method for lung cancer. Even when something that looks like a predictor of cancer is found, such as a nodule on the lung during a CT scan, it is still not a foolproof way to determine who will get cancer, Dr. Spivack said. "What we find in middle-age smokers is that 20-80% of these people have nodules,” he said. "But 95% of the nodules are not cancer and are not going to be.”

"The concept of testing exhaled breath is not new--that [is] what breathalyzers do when they measure small volatile molecules such as alcohol, as well as inflammation molecules that are currently being assayed to test the activity of asthma and other lung diseases,” said Dr. Spivack. "But what is rather remarkable here is that DNA can be tested in the air that comes from the lungs and airways, and that it might be possible to use this in diagnosis of lung cancer in particular, and gene-dysregulation disorders of the lung, in general.”



Related Links:
Wadsworth Center

New
Gold Member
Breast Imaging Monitor
Barco Coronis Onelook MDMC-32133 32MP
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
POC Respiratory/Sore Throat Test
BIOFIRE SPOTFIRE (R/ST) Panel
Pediatric Mask
Respire SOFT
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: New findings show that chemotherapy plus immunotherapy before surgery produced greater tumor destruction than immunotherapy alone in head and neck cancer patients (Image Credit: Adobe Stock)

Combination Therapy Before Surgery Drives Stronger Tumor Reduction in Head and Neck Cancer

Patients with head and neck cancer who are scheduled for surgery often face a waiting period with limited treatment, creating an opportunity to reduce viable tumor burden before the operation.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.